Leading Operational Excellence in a Global Company

Mark McColgan ()
Additional contact information
Mark McColgan: Takeda Pharmaceuticals International

Chapter Chapter 26 in Leading Pharmaceutical Operational Excellence, 2013, pp 411-418 from Springer

Abstract: Abstract Most pharmaceutical companies have introduced Operational Excellence (OPEX) programs to optimize quality, costs, and time. Many of those responsible for OPEX have tried to identify the key factors leading to a successful implementation of OPEX. Identifying these factors is especially interesting against the backdrop that more than a few OPEX programs fail during implementation. This article reflects on the importance of leadership at company and individual level for the successful implementation of OPEX programs.

Keywords: Emotional Intelligence; Shop Floor; Total Quality Management; Employee Involvement; Corporate Level (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-642-35161-7_26

Ordering information: This item can be ordered from
http://www.springer.com/9783642351617

DOI: 10.1007/978-3-642-35161-7_26

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().